Document Detail


Reduced susceptibility to ischemia-induced arrhythmias in the preconditioned rat heart is independent of PI3-kinase/Akt.
MedLine Citation:
PMID:  19627174     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We examined the involvement of phosphatidylinositol 3-kinase (PI3K) and its effector protein kinase B (Akt) in cardioprotective effects of ischemic preconditioning (PC) with particular regards to its role in the protection against ischemia-induced arrhythmias in isolated perfused rat heart. PI3K/Akt inhibitor wortmannin (100 nM) was administered 15 min prior to 30-min regional (left anterior descending coronary artery occlusion) ischemia for the study of ischemic arrhythmias in the hearts perfused at constant coronary flow or prior to 30-min global ischemia followed by 2-h reperfusion for the infarct size (IS) determination (tetrazolium staining) in the hearts perfused at constant pressure. PC procedure (one cycle of ischemia/reperfusion, 5 min each) significantly reduced the total number of ventricular premature complexes (PVC) and severity of arrhythmias (arrhythmia score; AS) over the whole period of left anterior descending coronary artery occlusion in comparison with non-PC controls (PVC 166+/-40; AS 1.6+/-0.2 vs. 550+/-60 and 3.2+/-0.2; respectively; P<0.05). In a setting of global ischemia/reperfusion, PC decreased IS (in % of the left ventricle, LV) by 73 %. Pretreatment with wortmannin modified neither arrhythmogenesis nor IS in the non-PC hearts. Bracketing of PC with wortmannin did not abolish antiarrhythmic protection (PVC 92+/-25; AS 1.7+/-0.2; P<0.05 vs. non-PC hearts). On the other hand, wortmannin increased IS/LV in the PC hearts to 24+/-1.2 % as compared with 9 +/- 0.6 % in the untreated ones (P<0.05). In conclusion, PI3K/Akt inhibition did not affect reduced arrhythmogenesis during ischemia in the PC hearts indicating that in contrast to its positive role in the irreversible myocardial injury, PI3K/Akt activity is not required for protection induced by PC against ischemic arrhythmias in the rat heart.
Authors:
T RAVINGEROVA; J MATEJIKOVA; D PANCZA; F KOLAR
Related Documents :
16159814 - Bradykinin preconditioning improves the profile of cell survival proteins and limits ap...
16543634 - Cardioprotective effect of hydroxyfasudil as a specific rho-kinase inhibitor, on ischem...
11491204 - Clinical importance of stunned and hibernating myocardium.
11401144 - Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit del...
15007014 - L-arginine transport in the human coronary and peripheral circulation.
1109324 - The echocardiogram of the anterior leaflet of the mitral valve. correlation with hemody...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Physiological research / Academia Scientiarum Bohemoslovaca     Volume:  58     ISSN:  0862-8408     ISO Abbreviation:  Physiol Res     Publication Date:  2009  
Date Detail:
Created Date:  2009-07-24     Completed Date:  2009-09-02     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9112413     Medline TA:  Physiol Res     Country:  Czech Republic    
Other Details:
Languages:  eng     Pagination:  443-7     Citation Subset:  IM    
Affiliation:
Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic. usrdravi@savba.sk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
1-Phosphatidylinositol 3-Kinase / antagonists & inhibitors,  metabolism*
Androstadienes / pharmacology
Animals
Arrhythmias, Cardiac / enzymology,  etiology,  prevention & control*
Ischemic Preconditioning, Myocardial*
Male
Myocardial Infarction / enzymology,  etiology,  prevention & control*
Myocardial Ischemia / complications,  enzymology,  therapy*
Myocardial Reperfusion Injury / enzymology,  etiology,  prevention & control*
Myocardium / enzymology*,  pathology
Perfusion
Protein Kinase Inhibitors / pharmacology
Proto-Oncogene Proteins c-akt / antagonists & inhibitors,  metabolism*
Rats
Rats, Wistar
Chemical
Reg. No./Substance:
0/Androstadienes; 0/Protein Kinase Inhibitors; 19545-26-7/wortmannin; EC 2.7.1.137/1-Phosphatidylinositol 3-Kinase; EC 2.7.11.1/Proto-Oncogene Proteins c-akt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabolic profile and sex hormone binding globulin (SHBG) in different reproductive phases of Czech ...
Next Document:  Simvastatin alleviates myocardial contractile dysfunction and lethal ischemic injury in rat heart in...